B2B manufacturing unicorn Zetwerk has raised ₹43 crore in a funding round co-led by Arc Investments and Oriental Biotech Limited. The company board passed a special resolution on February 25 to raise the sum through issuance of 9,93,721 Series F3 compulsorily convertible preference shares at an issue price of ₹432.718 per share.